Therefore, treatment generally begins with a low dose, gradually increasing to minimize gastrointestinal side effects
When adding tirzepatide to existing insulin therapy, consider an initial 10-20% reduction in basal insulin dose, with greater reductions (up to 20-30%) for patients with A1C levels near target
Reported effects Supports reduction in fat mass Enhances lipolysis (fat breakdown) May promote lean muscle gains Stimulates sustained growth hormone and IGF-1 Selective growth hormone release, avoiding cortisol/prolactin increases Favorable safety profile observed with AOD-9604 Reported side effects Mild injection site reactions (redness, itching) Transient flushing or warmth Occasional headache or lightheadedness Mild water retention Storage Lyophilised (unmixed) Store at -20 C (-4 F) in dry, dark conditions, minimizing moisture
By reducing regulatory barriers and enabling pharmacist-level substitution without requiring a new prescription, experts expect biosimilars to follow adoption curves closer to those of traditional generics
Poor sleep is associated with increased hunger hormones (ghrelin) and reduced satiety signals, which works against tirzepatides appetite-reducing mechanism